Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Gufic Biosciences

BSE: 509079|NSE: GUFICBIO|ISIN: INE742B01025|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 17, 15:30
113.05
-3.6 (-3.09%)
VOLUME 9,725
LIVE
NSE
Jul 17, 15:29
114.50
-2.25 (-1.93%)
VOLUME 66,979
Announcements on Gufic Bio

13th-Jul-2018 14:42Source: BSE

Gufic Biosciences- Shareholding for the Period Ended June 30, 2018

Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly

13th-Jul-2018 13:01Source: BSE

Gufic Biosciences- Statement Of Investor Complaints For The Quarter Ended June 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complai...

20th-Jun-2018 18:05Source: BSE

Gufic Biosciences- Board Meeting-Outcome of Board Meeting

Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Direc...

14th-Jun-2018 16:52Source: BSE

Gufic Biosciences- Intimation Of The Board Meeting Scheduled To Be Held On June 20, 2018.

Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,2015, we wish to inform you that a meeting of the Bo...

11th-Jun-2018 22:44Source: BSE

Gufic Biosciences- Statement On Impact Of Audit Qualification

Enclosed is the Statement on Impact of Audit Qualification for the financial year ending March 31, 2018.

You are requested to take the same on record.

31st-May-2018 16:50Source: BSE

Gufic Biosciences- Announcement under Regulation 30 (LODR)-Meeting Updates

This is to inform you that there are certain errors in the Audit Report issued by M/s. SHR & Co., Chartered Accountants (FRN : 120491W), Statutory Auditor of the Company submitted with the Stock Excha...

30th-May-2018 16:00Source: BSE

Gufic Biosciences- Board Meeting-Appointment of Director

Appointment of Mr. Balram Singh (DIN : 06918085) as Non-Executive Non-Independent Director of the Company for a term of three years w.e.f May 29, 2018, subject to the approval of shareholders.

30th-May-2018 15:59Source: BSE

Gufic Biosciences- Board recommends Dividend

Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2018, inter alia, have recommended Dividend @5% i.e. Re. 0.05 per equity share (Face Va...

30th-May-2018 15:43Source: BSE

Gufic Biosciences- Board Meeting-Outcome of Board Meeting

The Board of Directors of the Company at its Meeting held on May 29, 2018, which commenced at 8.45 p.m. and concluded at 03.25 p.m. on May 30, 2018, inter alia considered and approved the following :<...

30th-May-2018 10:27Source: BSE

Gufic Biosciences- Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly

Quick Links for Gufic Biosciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.